Cellectar Biosciences, Inc. - ROE
CLRB
Price:
$2.79
Market Cap:
$8.91M
Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemot...[Read more]
Industry
Biotechnology
IPO Date
2005-11-10
Stock Exchange
NASDAQ
Ticker
CLRB
PE Ratio
[-0.52]
ROE
[-264.79%]
Current Ratio
[1.90]
Dividend Yield
[0%]
Enterprise Value
[2.09M]
Dividend History
The ROE as of June 2026 (TTM) for Cellectar Biosciences, Inc. (CLRB) is -264.79%
According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -264.79%. This represents a change of 260.77% compared to the average of -73.40% of the last 4 quarters.
Cellectar Biosciences, Inc. (CLRB) Historical ROE (quarterly & annually)
How has CLRB ROE performed in the past?
The mean historical ROE of Cellectar Biosciences, Inc. over the last ten years is -108.22%. The current -264.79% ROE has changed 144.67% with respect to the historical average. Over the past ten years (40 quarters), CLRB's ROE was at its highest in in the June 2023 quarter at 2.18%. The ROE was at its lowest in in the March 2024 quarter at -191.90%.
Average
-108.22%
Median
-112.97%
Minimum
-333.42%
Maximum
310.45%
Cellectar Biosciences, Inc. (CLRB) ROE by Quarter and Year
Discovering the peaks and valleys of Cellectar Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 356.75%
Maximum Annual ROE = 310.45%
Minimum Annual Increase = -200.46%
Minimum Annual ROE = -333.42%
| Year | ROE | Change |
|---|---|---|
| 2025 | -219.69% | -29.56% |
| 2024 | -311.87% | -200.46% |
| 2023 | 310.45% | -193.11% |
| 2022 | -333.42% | 356.75% |
| 2021 | -73.00% | 165.00% |
| 2020 | -27.55% | -82.29% |
| 2019 | -155.56% | 55.82% |
| 2018 | -99.83% | -20.83% |
| 2017 | -126.11% | 176.28% |
| 2016 | -45.65% | -86.30% |
Cellectar Biosciences, Inc. (CLRB) Average ROE
How has CLRB ROE performed in the past?
The current ROE of Cellectar Biosciences, Inc. (CLRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-73.70%
5-year avg
-125.51%
10-year avg
-108.22%
Cellectar Biosciences, Inc. (CLRB) ROE vs. Peers
How is CLRB’s ROE compared to its peers?
Cellectar Biosciences, Inc.’s ROE is less than AEON Biopharma, Inc. (223.66%), greater than Bolt Biotherapeutics, Inc. (-100.90%), greater than Cingulate Inc. (-365.16%), greater than Sensei Biotherapeutics, Inc. (-283.67%), less than Lyra Therapeutics, Inc. (1.21%), greater than Imunon, Inc. (-341.23%), greater than Marker Therapeutics, Inc. (-73.29%), less than Evogene Ltd. (937.72%), greater than TransCode Therapeutics, Inc. (-99.39%), greater than Mustang Bio, Inc. (-35.38%),
| Company | ROE | Market cap |
|---|---|---|
| 223.66% | $7.90M | |
| -100.90% | $7.67M | |
| -365.16% | $27.97M | |
| -283.67% | $18.59M | |
| 1.21% | $781.13K | |
| -341.23% | $4.59M | |
| -73.29% | $14.36M | |
| 937.72% | $4.52M | |
| -99.39% | $4.47M | |
| -35.38% | $4.93M |
Build a custom stock screener for Cellectar Biosciences, Inc. (CLRB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cellectar Biosciences, Inc. (CLRB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cellectar Biosciences, Inc.'s ROE?
How is the ROE calculated for Cellectar Biosciences, Inc. (CLRB)?
What is the highest ROE for Cellectar Biosciences, Inc. (CLRB)?
What is the 3-year average ROE for Cellectar Biosciences, Inc. (CLRB)?
What is the 5-year average ROE for Cellectar Biosciences, Inc. (CLRB)?
How does the current ROE for Cellectar Biosciences, Inc. (CLRB) compare to its historical average?